Hematopoiesis first arises in the extraembryonic yolk sac, and it is generally believed that yolk sac-derived stem cells migrate and seed the ietal liver at approximately week 6 of development in humans. Recently, the identification at day 8.5 to 9 of multipotential stem cells in intraembryonic sites different from the liver suggests that the establishment of hematopoiesis might be more complex than initially believed. In an attempt to understand initial steps of hematopoiesis during human ontogeny. we characterized clonogenic myeloid progenitor cells in human yolk sacs and corresponding embryos at 25 to 50 days of development. Most erythroid colonies derived from the yolk sacs differad from adult marrow-derived progenitors in that they also contained cells of the granulomacrophagic lineage, suggesting that they were pluripotent and exhibited a different response to cytokines. Furthermore, a subclass of nonerythroid progenitors generated very large granulomacrophagic colonies, some of which generated secondary ery-HE SEQUENCE of events during mouse development has clearly established that the extraembryonic yolk sac is the initial site of hematopoiesis, which begins at approximately day 7.1-3 Progenitor cells undergoing differentiation toward the B lymphoid pathway were also detected in the embryonic body at approximately day 8 to 9, although some controversy exists on the exact time that such cells are first detected4" and whether these intraembryonic progenitor cells derive from intraembryonic tissues or from stem cells migrating from the yolk sac and seeding the fetal liver."' There is no direct experimental evidence for the latter hypothesis. In contrast, emergence of stem cells in the embryonic body has received support in birds, where yolk sac and fetal liver hematopoiesis are independent events," and more recently, in Thus, two groups have shown that some primitive stem cells, identified in vivo by their repopulating ability,"',12 or in vitro by their ability to generate cells from all myeloid and lymphoid lineages," originate in the paraaortic splanchnopleura'"." or in the aorta-gonad-mesonephros (AGM) region.12 Preservation of primitive yolk sacderived hematopoiesis contrasting with altered fetal liver erythropoiesis observed in knockout mice for c-myb" and some transcriptional factorsI4 also give credit to the hypothe- 0 1998 by The American Sociery of Hematology. 0006-4971/98/8612-0022$3.00/0 4474 throid colonies on replating. Analysis of the distribution of progenitors revealed that in contrast to erythroid progenitors, whose numbers were equally distributed between the yolk sac and the embryo, 80% of the nonerythroid progenitors were found in the embryo at stages II and 111. Interestingly, a high proportion of nonerythroid progenitors (including high proliferative potential cells) was present in colony assays initiated with cells remaining after the liver has been removed. These findings were validated in colony assays established with CD34' cells purified from extraembryonic yolk sacs and intraembryonic tissues. Increased knowledge about the biology of hematopoietic stem cells early in life may help to further understanding of the mechanisms associated with the restriction in proliferative and differentiative potential observed in the adult hematopoietic stem cell compartment.
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sis of extrahepatic sites for hematopoietic production. In contrast with the accumulation of evidence demonstrating extensive potentialities for intraembryonic hematopoietic stem cells, little is known on the properties of yolk sac progenitor cells. Committed progenitor cells of multiple myeloid and lymphoid lineages have been found in the mouse and in the human yolk sac,1.7,15-18 but very few studies have identified day-12 spleen colony-forming units (CFU-S), ' .]' and the existence of long-term reconstituting cells in the yolk sac is still debated.".I9 Characterization of the hematopoietic stem cell properties early in life will be important in view of recent observations that suggest age-related restrictions in the proliferative capacity'" and potentialities"." of primitive progenitor cells. Thus, individual progenitor cells with a primitive phenotype (CD34++/Thyl+) isolated from bone marrow of 16-to 18-week-old human fetuses generate myeloid and B lymphoid cells in vitro with a high frequency." CD34+ cells from fetal liver or marrow also produce, in some conditions, T-lymphocyte precursors" and easily reconstitute severe combined immunodeficiency (SCID) mice,24 whereas the potential of phenotypically identical adult marrow cells maintained in similar culture conditions is restricted to the myeloid lineages. Also important in this context is the observation that amplification of CD34' cells might be more efficiently obtained in vitro from hematopoietic tissues of fetal origin. 25 In this study, we characterized in detail the number and potential of clonogenic hematopoietic progenitors in human yolk sacs and corresponding embryonic bodies between 30 and 50 days of development. Both erythroid and nonerythroid progenitor cells were detected in colony assays initiated with yolk sac cells but also with cells from the embryos. Unique morphologic features and cytokine requirements of colonies observed in colony assays of yolk sac and intraembryonic cells suggest that the progenitors were endowed with properties that distinguished them from adult marrow-derived progenitors. This was particularly true of pluripotent, high proliferative potential progenitors that were detected almost exclusively in the embryo outside the liver. sug- 
MATERIALS AND METHODS

Sample Collection and Staging
Abortion products were collected after termination of pregnancy by administration of oral mifepristone and parental misoprostol (prostaglandin E l [PGEl]). The project was approved by the National Ethics Committee, and written consent was obtained from every patient. Yolk sacs and corresponding embryos were dissected free of the surrounding tissues and the stage of development was estimated by measuring crown-rump length (CRL) and by examining general developmental features of the embryo as reported by Hamilton and Mossman." Although the menstrual history of every patient was available, we chose to classify the embryos according to their morphologic stage of development. We analyzed 34 yolk sacs and 35 embryos. Using CRL and development features described by Hamilton and Mossman,26 we distinguished four stages of development. Prominent features of stage I (approximately 25 to 30 days) included a large connection between yolk sac and midgut, an elongated embryo, poor vascularization, absence of clear liver rudiment under the microscope. Embryos at stages I1 (approximately 30 to 35 days) and 111 (35 to 40 days) were markedly curved, with marked pontine and cervical flexures and apparent limb buds. The yolk sac was connected to the embryo through a long vitelline duct, which facilitated its separation from the embryo. Stages I1 and I11 were mscriminated by the subdivision of limb buds in stage 111, an obvious liver rudiment, marked forebrain vesicles, and cervical and pontine flexures. Four embryos at stage IV (greater than 40 days) were also obtained. The liver rudiment was clearly identified under the microscope at stage 111, and whenever possible, it was dissected and analyzed separately.
Unique technical difficulties due to the collection of human embryos were encountered in this study and deserve two comments.
(1) The earliest human embryos used in this study were at approximately 25 days of development, which is probably later than the time at which intraembryonic progenitors were first identified in the mouse species. (2) Individual experiments were performed from one sample generating low numbers of cells, a limitation that precluded detailed comparisons within each experiment.
Cell Preparation
Extraembryonic yolk sacs and embryos were separately digested enzymatically in 0.1% collagenase in Hanks' balanced salt solution (HBSS) supplemented with 30% fetal calf serum (FCS; JBIO Laboratory, Les Ulis, France) and DNAse (type I, 100 mg/mL; Sigma, St Louis, MO). Ten fetal livers were also prepared using a similar procedure. Cells were incubated for 30 to 90 minutes at 37°C in the enzyme solution, vigorously pipetted to dissociate the tissues, pelleted, washed once, and incubated overnight in tissue culture dishes in a-minimal essential medium (aMEM) plus 30% FCS at 37"C, 5% COz. This step facilitated the dissociation of aggregates present in the cell suspension immediately after collagenase digestion. These strongly adhered and spread during the overnight incubation. Cytokines, recombinant human (rhu) stem cell factor (SCF; supplied by AMGEN; Thousand Oaks, CA), interleukin (1L)-3, IL-6 (supplied by Genetics Institute, Cambridge, MA), and erythropoietin (Epo; AMGEN), were systematically added during the incubation period to minimize cell death. The next day, nonadherent cells were collected, and adherent cells were detached with trypsin in a singlecell suspension, washed, and pooled with the nonadherent cells. Pooled cells were counted and plated in methylcellulose assays supplemented with various combinations of recombinant growth factors (see below).
Isolation and lmmunophenotyping of CD34+ Cells From Yolk Sac, Embryonic Liver, and Extrahepatic Embryo
Immunologic phenotyping was performed in three samples on cell suspensions obtained as described above from liver, embryo, and extraembryonic yolk sac, except that adherent cells were recovered after overnight incubation with a nonenzymatic solution (Sigma Chemicals). Cells were labeled in uMEM supplemented with 5% FCS and 100 pg/mL DNAse (type I; Sigma Chemicals) with phycoerythrin (PE)-conjugated HPCA-2 monoclonal antibody (MoAb; CD34) and one of the following MoAbs directly coupled to fluorescein isothyocyanate (FITC) and recognizing the following antigens: CD38, CD19 (Becton Dickinson, San JosB, CA), CDIlb, CD33, HLA-DR, GPIIIa (CD61; Dako, Trappes, France), Thy1 (Pharmingen, San Diego, CA), and Ulex Europeaus (Vector Laboratories). Acquisition of at least 10,OOO events was performed on a FACSsort (Becton Dickinson). Analysis of the data was performed with the Cellquest software (Becton Dickinson). Systematically, 7-amino-a~-tinomycine D (7-AAD; Sigma) was added to the samples, and a gate was defined that included only 7-AAD-negative (viable) cells. Compensation was set up with control cells stained with CD34-PW In four experiments, CD34' cells were sorted from yolk sac, liver, and embryonic cell suspensions labeled with the PE-HPCA-2 MoAb on a FACS Vantage (Becton Dickinson) equipped with an INNOVA 70-4 Argon ion laser (Coherent Radiation, Palo Alto, CA) tuned at 488 nm and operating at 500 mW. Positivity for the CD34 antigen was determined in the 7-AAD-negative gate using a PE-irrelevant IgG1. To eliminate the CD34', 7-AAD-negative debris with a very low forward side scatter, which usually contaminated the sorted fraction and may indicate cell death in the CD34+ population, we selected 7-AAD-CD34' cells with a forward side scatter higher than 300.
IgGl -FITC and CD38-FITCAgGl-PE.
Assessment of Hematopoietic Progenitor Cells in
Semisolid Colony Assays
Nonadherent cells were plated in 0.8% methylcellulose in Iscove's modified Dulbecco's medium (purchased from Stem Cell Technologies, Vancouver, Canada) supplemented with 30% FCS, 1% deionized bovine serum albumin (BSA), and m o m 0-2 mercaptoethanol. Optimal conditions for detecting erythroid progenitors included rhuEpo (2 U/mL), rhuSCF (50 ng/mL), and rhuIL-3 (100 U/mL).
For assessment of granulocytic progenitors, rhu granulocyte colonystimulating factor (rhuG-CSF; AMGEN) and rhu granulocyte-macrophage colony-stimulating factor (rhuGM-CSF; Immunex, Seattle, WA) were added to the previous cytokine combinations or used alone in independent dishes. The optimum concentrations of cytokines used in this study were defined in colony assays initiated with normal adult marrow cells. However, dose-response curves for rhuSCF and rhuEpo were performed with embryonic cells in three experiments. When colony assays were initiated with unfractionated cells, the concentration of cells per dish varied from between 1 X IO4 and 2 X lo4 to 2 X lo", depending on the total number of cells obtained after dissociation of the tissue. Thus, colony assays were established with 1.5 X IO4 to 2 X lo4 yolk sac cells per dish, 5 X lo4 to 10 X lo4 cells from the embryo, and 2 X IO" cells from the liver. CD34+ cells purified from the different compartments were plated at a concentration of 1,OOO to 2,000 cells per dish. Dishes were incubated at 37°C in an air atmosphere supplemented with 5% CO2 and saturated with humidity. Progenitors were scored several times: after 4 to 5 days in culture to not miss small erythroid colonyforming unit (Cm-E)-derived colonies/clusters and at days 8 to IO and 13 to 14 when large erythroid and nonerythroid colonies were present. Dishes were again scored at days 15 to 18. Typical small, hemoglobinized colonies (less than 100 cells) were scored as C mFor personal use only. on November 11, 2017. by guest www.bloodjournal.org From 4476 HUYHN ET AL E. Other hemoglobinized colonies were large and exhibited a very consistent and peculiar phenotype that distinguished them from standard burst-forming unit-erythroid (BFU-E)-derived colonies" or colony-forming unit-granulocyte, erythroid, monocyte, megakaryocyte (CFU-GEMM; see Results). Therefore, they were referred to as erythroid progenitors. A subclass of nonerythroid colonies also had a distinct morphology and a very large size (greater than 100,000 cells), indicating that they were derived from a progenitor with a very high proliferative potential (see Results) . These were scored separately also.
Analysis of Growth Factor RNA in the Yolk Sac and Embryos by Reverse Transcription-Polymerase Chain Reaction (RT-PCR)
RNA was extracted either from yolk sac and embryos frozen in liquid nitrogen without previous processing or from cells lysed in isothiocyanate guanidinium (isothiocyanate guanidium, 4 mol& sodium citrate, 25 mmol/L pH7; sarcosyl, 0.5%; and 2 mercaptoethanol, 0. I mol/L) after collagenase digestion. Total cellular RNA was isolated by the modified Chomczynski and Sacchi method adapted to small cell numbers.2x Presence of RNA encoding various cytokines was determined using the PCR method. First-strand cDNA was synthesized from total cellular RNA with hexanucleotides as primers with avian myeloblastosis virus (AMV) reverse transcriptase, as previously described." Presence of RNA in the sample was determined by the amplification of human 02-microglobulin gene, which is expressed at this stage of development (our unpublished observations, March 1994). Only samples in which we had observed the presence of RNA of human 82-microglobulin were tested by RT-PCR for cytokine expression. Primers specific for human GM-CSF, Epo, SCF, IL-3, and 82-microglobulin were chosen, as previously described in details,'" and amplification products were revealed by Southern blots using an oligonucleotide recognizing internal sequence. RNA extracted from human phytohemagglutininstimulated peripheral blood lymphocytes served as a positive control for GM-CSF and IL-3 primers, cells from the Hep G2 line for Epo, and human marrow fibroblasts for SCF.
RESULTS
Hematopoietic progenitor cells were assessed in 35 embryos and 34 yolk sacs. In 27 of these samples, the extraembryonic yolk sac and the embryo were from the same sample.
Characterization of Hematopoietic Clanogenic Progenitor Cells in the Yolk Sac
Both erythroid and nonerythroid progenitors generating colonies of more than 100 cells were found in every yolk sac studied (Fig 1) . The absolute number (mean ? SEM) of large erythroid colonies observed per yolk sac was very similar from stage I through IV: 106 ? 18 (n = 10) of these were detected at stage 1, 1 12 L 38 (n = 7) at stage 11, and 189 ? 51 (n = 8) at stage 111 (Fig 2) . Notably, high numbers (483 ? 247, n = 4) of large erythroid colonies were observed at stage IV in the yolk sac. However, as the mean number of nucleated cells per yolk sac increased from 1.1 X 1 0' ? 0.24 X 10' to 3.4 X 10' t-0.9 X 10' from stage I to IV, the concentration in erythroid colonies was, in fact, decreasing. Nevertheless, these numbers were far below the numbers of progenitors generating similar colonies present in the liver at stage IV of development (65,000 ? 25,700; n = 10).
By comparison, the decrease in nonerythroid progenitors as development progressed was more pronounced and was observed independently of results expression (per organ or per nucleated cells; Fig 1) . Thus, at stages I and 11, the absolute numbers of nonerythroid progenitors were comparable with those of erythroid progenitors ( Fig 3, with a tight center of hemoglobinized cells surrounded by dispersed cells. Cytologic examination of cytospun colonies revealed a majority of differentiated erythroblasts mixed with some macrophages and granulocytes in most of the colonies. The mixed phenotype of erythroid colonies was not reproduced for adult marrow-derived BFU-E but has been reported with cord blood BFU-E-derived colonies"' (and our unpublished observations, January 1995) and suggests that these colonies arise from a class of BFU-E with potentialities different from standard BFU-E. The rnorphology of' erythroblasts in the colonies was unremarkable and identical to that of erythroblasts found in adult marrow BFU-E-derived erythroid colonies. Notably, analysis of slides made with cells from embryos and yolk sacs before culture revealed that erythroid cells in all but one sample were nucleated with no nuclear expulsion.
(2) A second observation concerns the very low numbers of small hemoglobinized coloniesklusters derived from conventional CFU-E, even when dishes were first scored within 4 to S days after plating. The mean (?SEM) number of CFU-E per yolk sac was 9 5 6 at stage I. S ? 2.7 at stage 11, 36 2 20 at stage 111, and 30 2 13 at stage IV. In contrast, at stage W . 12,000 2 4,760
CFU-E were counted per liver (n = 10).
We next studied the growth factor requirements of progenitor cells generating large erythroid colonies. Growth of large erythroid colonies in vitro from yolk sac cells was absolutely dependent on the presence of rhuEpo. Some erythroid colonies grew in the presence of rhuEpo alone. However, their number was considerably increased by the addition of another cytokine. The mean (2SEM) fold-increase in the numbers of erythroid colonies induced by the addition of rhuIL-3. rhuSCF, or both to rhuEpo was 10 +-4 (n = 9) for rhuIL-3,6 +-3 (n = 9) for rhuSCF, and 2 1 t 4 when rhuEpo. rhuIL-3, and rhuSCF were present (Fig 4) . The effects of cytokines were independent of the stage of development. Interestingly, rhuSCF was usually less efficient than IL-3 in stimulating the development of erythroid colonies from the yolk sacs, a result that contrasted with what is usually observed with BFU-E from adult marrow. By comparison, in colony assays initiated with cells from embryonic livers, a substantial number of erythroid colonies developed in the presence of rhuEpo alone (Fig 4B) , and rhuIL-3, rhuSCF, and a combination of both increased the number of erythroid colonies (fold-increase) by 1.6 5 0.5 (n = 41, 2.1 t 0.4 (n = 4), and 2.4 t 0.4 (n = 7), respectively, over numbers observed with rhuEpo alone.
Dose-response curves for
For personal use only. on November 11, 2017. by guest www.bloodjournal.org From rhuEpo and rhuSCF in colony assays from three embryonic samples and control adult marrow cells simultaneously did not reveal major differences (data not shown): 50% maximal erythroid progenitor stimulation was seen in control marrow for rhuEpo concentrations of 10 to 50 mU/mL, and 0.5 U/ mL rhuEpo was required for optimum stimulation of colony 8oo U size and number. The effect of rhuSCF was first seen at 1 ng/mL, with maximal effect (judged by colony size) at 10 ng/mL.
Stage
Development of yolk sac-derived, nonerythroid progenitor cells also absolutely required the addition of cytokines, and although low numbers of cells in the starting sample precluded any detailed comparison of the effect of each granulocyte-specific cytokine on these progenitors, similar numbers were obtained with the combinations rhuSCF plus rhuIL-3 and rhuGM-CSF plus rhuG-CSF with or without the addition of agar leukocyte-conditioned medium (A-LCM; data not shown). Cytologic analysis of cytospun colonies showed mature granulocytes of the neutrophilic and eosinophilic lineages as well as macrophages.
Characterization of Hematopoietic Clonogenic Progenitor Cells Detected in the Embryo
Comparison of the numbers of progenitor cells found in yolk sacs and embryos. At each of the four developmental stages studied, the progenitor cell content was determined simultaneously in the extraembryonic yolk sac and in the corresponding embryo using standard colony assays (Figs 1  and 2) . Comparison of the absolute numbers of erythroid and nonerythroid progenitors found in the yolk sac and in the embryo revealed differences in the distribution of progenitor cells.
At stage I in every sample, the majority of erythroid progenitors (generating large erythroid colonies) was located in the yolk sac (Fig 1A) . However, at stage 11, higher numbers of erythroid progenitors were found in the embryo than in the yolk sac in three of seven samples. To better illustrate the different behavior of erythroid and nonerythroid progenitors, we calculated for each individual paired sample the ratio of absolute numbers of progenitor cells found in the embryo versus in the yolk sac. For erythroid progenitors, this ratio was 0.2 ? 0.1 at stage I, 3 2 Only liver-derived erythroid progenitors were studied at stage IV. Interestingly, although only small numbers of colonies were scored (which precludes any firm conclusion), erythroid progenitor cells from embryos exhibited the same response to cytokines as that described above for yolk sac erythroid progenitor cells and were dependent on the presence of Epo for the production of hemoglobinized colonies (data not shown). Also characteristic was the absence of CFU-E: 26 2 24, 21 ? 9, and 27 2 18 of these colonies were counted per embryo at stages I, 11, and 111, respectively (mean 2 SEM).
In contrast, the distribution of nonerythroid progenitors was unequal at stage 11 and later, and numbers of progenitors in the embryos were higher than those found in the corresponding yolk sacs. This was illustrated by a ratio between 
embryo-and yolk sac-derived nonerythroid progenitors of 7 ? 2.5 and 12 2 3.8 at stages 11 and Ill, respectively ( Fig  IB and Fig 2) .
In five experiments to determine whether these differences were explained by the hematopoietic activity of the liver, we analyzed separately the region of the liver rudiment and the remaining extrahepatic embryonic tissues. As shown in Table I , in experiments 1 through 3. the numbers of nonerythroid progenitors found in the liver rudiment were equal to or lower than numbers in the extrahepatic tissues, indicating that hematopoietic activity was not predominant in the liver. In contrast, in experiments 4 and 5 (Table l), one of which was from a stage IV embryo, very high numbers of erythroid colonies and, to a lesser extent, nonerythroid colonies were observed in assays initiated with cell suspensions from the -- and nine livers (B; stage IV) were plated in duplicate methylcellulose colony assays in the presence of rhuEpo alone (2 U/mL, 0). rhuEpo + rhuSCF (50 ng/mL, 01, rhuEpo + rhulL-3 (100 U/mL, 1, or rhuEpo + rhuSCF + rhulL-3 (W. Erythroid colonies were scored after 10 to 14 days in culture. As the response to cytokines was independent of the stage of development, results obtained from samples studied at different stages were pooled. Each histogram represents the mean (+SEMI of colony numbers found in the 10 yolk sac and nine liver samples.
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Embryos and yolk sacs were isolated, and the region of the hepatic rudiment was dissected out from the embryos and digested separately in 0.1% collagenase. In experiments l and 4, the cardiac cavities were separately assessed also. The hematopoietic progenitor content of all tissues was assessed in methylcellulose colony assays stimulated by Epo, SCF, and IL-3. Results are expressed either as absolute numbers of the indicated progenitors per organ or per lo5 plated cells.
Abbreviation: Exp, experiment.
liver, indicating that this organ was a major source of hematopoietic progenitors. In two experiments, progenitors present in the heart cavities were evaluated as an indicator of circulating progenitors ( Table 1) . IdentiJcation in the embryo of hematopoietic progenitors with a very high proliferative potential. A subset of nonerythroid progenitors exhibited a unique phenotype essentially characterized by the generation of very large colonies organized in clusters (see Fig 5) . These colonies contained a mean number of 7.3 X lo4 cells (n = 50), which were almost exclusively mature granulocytes and macrophages when examined after May-Griinwald-Giemsa staining of colonies individually plucked at days 12 to 14. These high proliferative potential progenitors represented 20% to 25% of nonerythroid progenitors, and optimal numbers of colonies were obtained in assays stimulated by rhuSCF and rhuIL-3. Cytokines classically used to stimulate granulocytic differentiation, ie, rhuG-CSF and rhuGM-CSF, increased neither the size nor the numbers of these macroscopic colonies over that observed with rhuSCF plus rhuIL-3. To determine if the potentialities of these progenitor cells were restricted to the granulomacrophagic lineage, we individually replated 84 of these colonies in a secondary methylcellulose assay in conditions used for primary assays. Of these 84 primary colonies, 25 (30%) gave rise to secondary colonies, and 9 of 25 generated both erythroid and granulocytic secondary colonies (Table 2), suggesting that the primary high proliferative potential progenitor was, in fact, pluripotent. No secondary macroscopic colonies were seen. By comparison, primary mixed erythroid colonies (n = 15) and granulocytic colonies were picked at days 14 to 15 from the same dishes and replated in similar conditions. As expected, 6 of 15 mixed colonies generated secondary colonies, mostly CFU-E (data not shown). Granulocytic colonies did not generate secondary colonies.
Interestingly, these very large granulomacrophagic colonies were detected preferentially in colony assays established with intraembryonic cells, and only very few were observed in colony assays initiated with yolk sac or liver cells. We have not found such progenitors in colony assays established with adult bone marrow stimulated only with rhuSCF, rhuIL-3, and rhuEpo, a combination that allowed the development of only small granulocytic colonies (data not shown). As detailed in the next section, these progenitor cells were present in assays established with low numbers of CD34' cells purified from human embryos.
Assessment by Colony Assays of the Hematopoietic Potential of CD34+ Cells Sorted From Yolk Sac, Liver, and Embryos
In four samples, cells were labeled with PE-HPCA2, sorted, and plated in methylcellulose colony assays (Table  3 ). In two experiments ( Table 3 , experiments 3 and 4), we assessed simultaneously the clonogenic potential of CD34' cells sorted from yolk sacs, livers, and extrahepatic parts of the embryos. The cloning efficiency of CD34' cells was 4.6% in the yolk sac (n = 2), 1.85% 2 0.77% in the embryo (n = 4), and 3.2% in the liver rudiment (n = 2). The total number of CD34+ clonogenic progenitors counted per organ approximated the total number calculated from assays performed with unfractionated cells (see Figs 1 and 2 and Table l), thus confirming that early in human ontogeny, clonogenic hematopoietic progenitor cells express the CD34 antigen. Importantly, unique phenotypic features reported above for erythroid and nonerythroid high proliferative potential progenitor-derived colonies grown in assays of unfractionated cells were also seen in colony assays initiated with low numbers of CD34+ cells, thus making it unlikely that accessory cells contributed to these results through the release of endogenous activities. CD34+ high proliferative progenitors generated colonies of on average 200,000 cells in assays supplemented with rhuSCF, rhuIL-3, and rhuEpo, and 4 of 10 primary colonies generated secondary granulocytic colonies after replating (see Table 2 , experiment 8). The distribution of progenitors in CD34+ assays paralleled that observed when assays were initiated with unfractionated cells. Although low numbers of progenitors precluded any firm conclusion, in both experiments where liver cells and nonliver embryonic cells were separately assessed, these macroscopic colonies were seen in assays from nonliver embryonic cells (respectively, 32 and 6.5), but none were detected among CD34+ cells of the liver rudiment from the same samples (Table 3, Flow cytometric analyses of CD34 subsets in yolk sac (Fig 6a), liver (Fig 6b) , and embryo (Fig 6c) were also performed: CD34' cells in the yolk sac and extrahepatic tissues of the embryo expressed neither CD38 nor CD33 antigen. This phenotype characterizes primitive hematopoietic progenitor cells in the adult marrow but may also be shared by endothelial cells and other nonhematopoietic cell 3) were individually lifted and replated in secondary colony assays in conditions identical to the primary assays. Secondary colonies of different phenotypes were scored at day 12.
Abbreviations: E, erythroid; G, granulocytic; E + G, presence of both subsets that represent a high proportion of embryonic CD34' c e k 3 ' Interestingly, a fraction of CD34' cells in the liver rudiment expressed CD38 (Fig 6b) . The Thy1 antigen was detected on a high proportion of CD34' and CD34-cells from all three tissues, as was the lectin Ulex Europeaus (data not shown). HLA-DR was undetectable, and CD1 1 b was expressed on a subset of CD34' cells and also on CD34-cells from another embryo (data not shown). These data have been confirmed on three different samples.
Expression qf Cyrokine Genes in Yolk Sacs and Embryos
As a first approach to characterize cytokines regulating human hematopoietic differentiation at early developmental stages, we examined by RT-PCR the expression of RNA coding for Epo, SCF, GM-CSF, and IL-3 in cells from six yolk sacs and five embryos. RNA was extracted either from tissues frozen immediately after collection (five embryos and six yolk sacs) or after collagenase digestion and overnight incubation (Fig 7 and Table 4) . No attempt was made to separate hematopoietic cells from nonhematopoietic components. The SCF gene was highly expressed in every sample, as expected from previous studies.." The Epo gene was transcribed in every sample examined from liver rudiment and yolk sac. In contrast, expression of GM-CSF and IL-3 genes was negative in ex vivo samples, but transcription of the GM-CSF gene, in contrast with that of IL-3, was induced in adherent cells from all three tissues after their incubation in culture.
DISCUSSION
In a search for models suitable for identifying expression of human hematopoietic stem cell self-renewal and multipotentialities, we started to investigate the properties of hematopoietic progenitors found very early in human ontogeny.
erythroid and granulocytic colonies in the same dish. showing that primitive progenitors with the most extensive potentialities and proliferation capacity might be found preferentially at early stages of development."s20321 As a first approach, we precisely evaluated the properties of hematopoietic clonogenic progenitor cells in different compartments of the human embryo and in the extraembryonic yolk sac. Our study extends previous results on the assessment of erythroid and nonerythroid progenitor cells in human yolk sacs at 5 to 7 weeks' and provides new information on the phenotype of these progenitor cells, their cytokine requirements, and their distribution between embryonic and extraembryonic compartments.
Use of this material was motivated by recent observations
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Most erythroid and some nonerythroid progenitors identified in human yolk sacs and embryos, when stimulated by rhuSCF and rhuIL-3, expressed properties that distinguished them as earlier cells than the BFU-E and CFU-GM identified in adult bone marrow using similar colony assays. Thus, most erythroid colonies included some macrophages and mature granulocytes, suggesting that the progenitor was pluripotent. Within the population of nonerythroid progenitors, a subset was identified that produced very large granulomacrophagic colonies in vitro in response to rhuSCF and rhuIL-3. Such properties characterized primitive high proliferative potential colony-forming cells (HPP-CFC) identified in agar colony assays of 5-fluorouracil (SW)-treated mouse bone marrow and that have been shown to be hierarchically close to in vivo repopulating cells33 and may also be shared by cord blood CD34+ progenitors." In addition to their high proliferative capacity, some of these progenitors identified in human embryos were pluripotent, as suggested by the replating capacity of primary colonies that yielded both erythroid and granulocytic secondary colonies. This result underlines the fact that a significant number of progenitors believed to be restricted to the granulocyte-macrophage lineage based on the phenotype of the primary colonies that they have generated may also be capable of erythroid differentiation or of lymphoid differentiation, as recently demonstrated in the mouse.35 However, the exact potential of these HPP-CFC-like progenitors and their position in the hematopoietic hierarchy remain to be elucidated in appropriate assays. Second, intraembryonic erythroid and nonerythroid progenitor cells expressed the CD34+ antigen, as demonstrated by the results of colony assays established with CD34+ cells purified from yolk sacs and embryos. These progenitors were negative for the CD38 and CD33 antigens, as suggested by flow cytometric analysis, although this is difficult to ascertain because the plating efficiency was very low and we did not directly analyze the clonogenic potential of sorted CD34+CD38-cells. Thus, all CD34+ cells from yolk sacs and embryos were negative for the expression of CD33 and CD38 antigens, a phenotype usually characteristic of immature progenitors, at least in adult bone m a r r~w .~~.~' It is possible, however, that during ontogeny the expression of antigens classically used to subdivide CD34' cells will prove to be different from what is expected at a given maturation stage based on results reported with adult cells. Phenotypic analysis might also be skewed by uncontrolled technical problems inherent to the use of human embryos, such as selective loss of more mature CD34+CD38+ progenitors during the time elapsed between chemical induction of abortion and collection of the samples.
Nevertheless, results from colony assays performed with CD34+ cells purified from embryonic sources confirmed that unique features observed in colony assays established with unfractionated cells did not result from the endogenous release of stimulatory molecules by accessory nonhematopoietic cells contaminating the assay, but rather resulted from unique, intrinsic properties of the progenitors. The contribution of cytokines produced by cells within the colony itself is still possible and will have to be further analyzed.
The distribution of progenitor cells between yolk sac and intraembryonic tissues that we observed also raised some questions: high numbers of both erythroid and nonerythroid progenitor cells were consistently detected in the embryo as early as stage I. Second, nonerythroid progenitors were predominantly found in the embryo, whereas erythroid progenitors were more equally distributed. Thus, at stages I1 and III, there were 7 to 10-fold more nonerythroid progenitors but only twofold more erythroid progenitors in the embryo as compared with the extraembryonic yolk sac. Because the whole embryo was digested, we could not determine whether the cells were circulating or arose from a precise intraembryonic source. The liver is the primary hematopoietic organ from 6 weeks of development in humans, but in other species, hematopoietic activity has clearly been demonstrated earlier in other intraembryonic regions. In birds, the analysis of histologic sections and the use of chimeras have proven that definitive hematopoiesis arises from the paraaortic region: and more recently, hematopoietic stem cells capable of generating myeloid and B-and T-lymphoid cells have been localized in the paraaortic splanchnopleura and AGM region of mouse embryos at days 8.5 to The existence of intraaortic sites of hematopoietic production has also been suggested on histologic sections of human embryos at stage 11, and this region has been shown to produce clonogenic progenitors in short term assays. However, direct proof that the CD34+ cells identified on tissue sections can express hematopoietic potential in functional assays is still lacking?'"
Although we can only speculate on the origin of intraembryonic progenitors that we have identified in this study, three arguments, although indirect, suggest that they might not arise from the liver. The most convincing one is provided by the comparison of numbers of colonies observed in colony assays initiated with cells from the liver rudiment with those observed in colony assays from embryos from which the liver rudiment has been removed. High numbers of both erythroid and nonerythroid progenitors (up to 50% of all intraembryonic progenitors) were found in assays from both sources, and high proliferative potential progenitor cells generating large colonies (see Fig 5 ) were observed in colony assays from nonliver cells and were not observed in assays established with liver cells. This was true whether the assays were initiated with unfractionated or CD34+ cells. The predominant location of CFU-S in the AGM region outside the liver has also been demonstrated in the mouse." It is important to mention, however, that the distribution of progenitors within embryonic compartments is likely to vary very quickly, and that our observations probably hold true only at a very precise time of development corresponding to stages II to III. This does not question the fact that the liver is later the primary source of primitive stem cells. Finally, it should be mentioned that our finding of hematopoietic activity in the yolk sac does not necessarily prove that progenitors were produced in situ, and the observation that a For personal use only. on November 11, 2017. by guest www.bloodjournal.org From Fig 7. PCR analysis of cytokine expression in samples from human yolk sacs, fetal livers, and embryos. cDNA was prepared from total cellular RNA extracted from positive control (first line), negative control (water; second line), and different samples of fetal livers (FL), yolk sacs (YS), and embryos (E). YS8, E8, YS12, FL13, FL15, FL18, El9a, E19b. and YS20 refer t o samples analyzed either ex vivo or directly after collagenase treatment. In some samples, cells dissociated with collagenase were incubated overnight, and nonadherent (NA) or adherent (A H241 cells were used for PCR analysis. Some adherent cells were used after two (P2), three (P3). or four (P41 passages in culture. Hybridization was performed with "P-labeled appropriate internal oligonucleotides for human SCF (A), GM-CSF (B), IL-3 (C), and Epo (D). RNA was extracted from the different organs either immediately after collection (ex vivo) of the samples or after enzymatic treatment and overnight incubation.
Abbreviations: Adh, adherent cells after 24 hours of incubation (24h) or after two (P2). three (P3), or four (P41 passages; N Adh, nonadherent cells.
The presence of RNA encoding Epo, GM-CSF, 11-3, or SCF was determined using the PCR method. Numbers refer t o the number of positive samples.
t Only four samples were tested for the presence of Epo mRNA. few high proliferative progenitors were, indeed, observed in yolk sac colony assays could indicate their migration from an external site. With respect to that question, analysis of globin gene expression in individual colonies grown from the different embryonic sources will be helpful.
Comparison of the biologic properties of progenitors grown from intra-and extrahepatic embryonic cells may also provide meaningful indications. Thus, the Epo response of intraembryonic progenitors differed from that observed for progenitors detected in assays from liver suspensions, in that Epo alone did not stimulate the growth of extrahepatic embryonic erythroid progenitor cells, but triggered the development of a high number of large erythroid colonies from liver cells, as previously described at later developmental ~t a g e s .~' .~~ Also, typical CFU-E were usually not detected in colony assays initiated with cell suspensions from extrahepatic embryonic cells or yolk sacs, but were present in high numbers in colony assays from fetal liver cells. Such inappropriately low numbers of CFU-E have already been reported in mouse yolk sacs13*16 but not in human yolk sac.' A parallel could be drawn with the adult situation, where no CFU-E circulate and circulating BFU-E, although originating in the marrow, express properties different from those of marrow-derived BFU-E."" CFU-E may also have been lost during the time elapsed between abortion induction and collection of the products or may be hypersensitive to collagenase, although mechanical dispersion of yolk sac cells in two experiments did not result in an increase in CFU-E numbers. None of these conditions, however, was detrimenFor personal use only. on November 11, 2017. by guest www.bloodjournal.org From tal to fetal liver-derived CFU-E processed simultaneously, and neither collagenase nor trypsin treatment were toxic to adult marrow4' or liver CFU-E (data from this study and Rich4*).
Despite the heterogeneity in the response of erythroid progenitors from different embryonic sources to Epo alone, production of hemoglobinized erythroblasts from both yolk sacs and embryonic progenitors was absolutely dependent on the addition of rhuEpo, and we did not detect any hypersensitivity to either this hormone or rhuSCF. This point is still controversial in the literature, and the growth of pure erythroid embryonic liver progenitors in the presence of SCF only has been reported, which may be partly explained by the local production of E~O .~' .~ With respect to the in vivo situation, the biologic significance of the in vitro cytokine response of progenitors is unclear. In vivo, mRNA encoding SCF and Epo were both detected in embryos or yolk sacs, but neither IL-3 nor GM-CSF genes were transcribed. Similar cytokine transcription patterns have been reported in day-8.5 mouse embryo and yolk sacs and also within embryoid bodies where hematopoiesis develops efficiently in the absence of added growth factors.& It is possible that the proliferation and differentiation of intraembryonic hematopoietic progenitor cells are under the control of as yet unidentified molecules produced by unique local yolk sac or embryonic environments during embryonic development.
The results described in this study suggest that progenitor cells identified in the human yolk sac, embryo, and liver differ based on their potentialities and response to cytokines. The next challenge will be to investigate the ability of individual CD34' cells purified from yolk sacs and different parts of the embryos to generate differentiated cells of myeloid lineages and to undergo commitment into the B and T lineages using long-term culture assays on competent stromal cell^^'^"^^^ or in vivo mouse chimeric reconstitution assay^?^,^^ This may help in gaining an understanding of the potential age-related mechanisms associated with restriction of potential in the hematopoietic stem cell compartment.
